| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |